Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone
Study Details
Study Description
Brief Summary
The purpose of this study is to compare changes of minimally invasive arterial pulse contour cardiac output with changes of intermittent and continuous thermodilution cardiac output by pulmonary artery catheter in hemodynamic unstable patients with rapid changing vascular tone (changing dosage of vasoactive drugs or inotropics, or volume challenge). Simultaneously, global parameters of oxygen delivery and consumption will be compared with regional flow parameters and tissue oxymetry (near infrared spectrometry and laser-Doppler). While continuous thermodilution cardiac output is used for patient management, pulse contour cardiac output, intermittent thermodilution cardiac output and tissue oxymetry is only used for monitoring.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
- Changes of cardiac output measured by three different techniques during changes of vascular tone [2 hours]
Secondary Outcome Measures
- Prediction of fluid responsiveness with minimally invasive arterial pulse contour analysis in hemodynamic unstable patients. [2 hours]
- Comparison of global parameters of oxygen delivery and consumption with local parameters of flow and tissue oxymetry during changes of vascular tone. [2 hours]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Indication for invasive hemodynamic monitoring with pulmonary artery catheter and arterial catheter
-
Hemodynamic instability (need for vasoactive drugs, inotropics or volume).
Exclusion Criteria:
-
Age < 18.
-
Patient with contraindications for the placement of arterial cannula.
-
Patient with history or clinical findings of aortic valve regurgitation.
-
Atrial fibrillation.
-
Patient being treated with an intra-aortic balloon pump.
-
Limitation of therapy due to bad prognosis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Intensive Care Medicine, University Hospital Inselspital, Berne | Bern | Switzerland | 3010 |
Sponsors and Collaborators
- University Hospital Inselspital, Berne
- Edwards Lifesciences
Investigators
- Principal Investigator: Christoph C Ganter, M.D., Department of Intensive Care Medicine, University Hospital, Inselspital, Berne
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KEK-3107-UHB-1316